Oral Oresentation 3

2:30 PM - 2:36 PM JST(5:30 AM - 5:36 AM UTC)

[O03-06] Clinical effectiveness of Vedolizumab in Chinese patients with Crohn's Disease: interim results from the VALUE study

Li Li¹, Xiaoqi Zhang², Yaqiu Hu³, *Li Xie³, Minhu Chen¹ (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 510080, 2. Nanjing Drum Tower hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing China,210003, 3. Takeda Pharmaceutical Company, Shanghai, China, 200126)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.